Pharmaleksp. z o.o.
Activities of head office and holding companies, excluding financial holding companies
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2016-02-17
Share capital
5,000.00 PLN
Registered address
ul. Hoża 50/1, 00-682 Warszawa, Poland
Electronic delivery address
AE:PL-22802-79906-ERHUU-12
Financials
Revenue history
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 6 days late).
- 2025filed
- 202415/07/2025
- 202311/07/2024
- 202213/07/2023
- 202121/07/2022
- 202013/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Activities of head office and holding companies, excluding financial holding companies2,812 / 3,898
Top 72%
Results vs industry
Revenue
This companyUSD 2.74kMedianUSD 29.13kAverageUSD 6.04m
Net profit
This companyUSD 2.10kMedianUSD 325.62AverageUSD 834.40k
Operating costs
This companyUSD 632.85MedianUSD 14.45kAverageUSD 4.72m
Assets
This companyUSD 2.25kMedianUSD 87.21kAverageUSD 17.31m
Industry
Authorized Representatives
Chukwuemeka Henry Mmereoleage 57 – Management Board Member
Jarosław Rejzmundage 54 – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 50 | $675.31 | 50% | |
Jarosław Rejzmundage 54 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-06-27.
36 2130 0004 2001 0731 1699 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $3,732.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 3, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,308$2,308 | Polski Fundusz Rozwoju S.A. | |
| Jun 29, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $71$71 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Qemetica Venturessp. z o.o. | $4,802.26 | qemetica.com | ||
| Di-Zetsp. z o.o. | $4,563.07 | di-zet.pl | ||
| Respectairsp. z o.o. | $4,035.03 | respectair.eu | ||
| Greenfield Macrosp. z o.o. | $2,567.39 | greenfield.eu.com | ||
| Solaris Ventum Capital 1sp. z o.o. | $2,544.55 | solarisventum.pl | ||
| T&T Groupsp. z o.o. | $2,147.63 | kancelaria-legalis.pl | ||
| Powerway Groupsp. z o.o. | $1,190.11 | powerway.com.pl | ||
| BB BiznesS.K.A. | $1,045.20 | bb-biznes.pl | ||
| Chargein Holdingsp. z o.o. | $683.26 | chargein.pl | ||
| Solter Capital Partnerssp. z o.o. | $10.28 | soltercapital.eu |
FAQ
Last updated: 2026-04-16